These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 240938)

  • 41. Bradykinin analogs as inhibitors of angiotensin-converting enzyme.
    Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS
    Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Competitive antagonists of bradykinin: in vitro (jugular vein) and in vivo (blood pressure response) studies.
    Hoffmann H; Whalley ET; Siebeck M; Weipert J; Fritz H
    Adv Exp Med Biol; 1989; 247B():407-9. PubMed ID: 2610085
    [No Abstract]   [Full Text] [Related]  

  • 43. Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule.
    Sleszyńska M; Wierzba TH; Malinowski K; Borovičková L; Małuch I; Sobolewski D; Lammek B; Slaninová J; Prahl A
    J Pept Sci; 2011 May; 17(5):366-72. PubMed ID: 21412955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amino-acids and peptides. Part 48. Synthesis of bradykinyl-chloromethane.
    Aplin RT; Christiansen J; Young GT
    Int J Pept Protein Res; 1983 May; 21(5):555-61. PubMed ID: 6885241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of rat urinary kinin as bradykinin.
    Hagiwara Y; Kojima M; Kuraishi T; Hayashi I; Miyata T; Oh-ishi S
    Life Sci; 1995; 57(10):997-1002. PubMed ID: 7643725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paramagnetic bradykinin analogues as substrates for angiotensin I-converting enzyme: Pharmacological and conformation studies.
    Teixeira LG; Malavolta L; Bersanetti PA; Schreier S; Carmona AK; Nakaie CR
    Bioorg Chem; 2016 Dec; 69():159-166. PubMed ID: 27837711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does insulin release kinins in rats?
    Damas J; Garbacki N; Lefèbvre PJ
    Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New acylated bradykinin analogues: effect on rat blood pressure and rat uterus.
    Dawidowska O; Prahl A; Wierzba T; Nowakowski L; Kowalczyk W; Slaninová J; Lammek B
    J Pept Sci; 2005 Jul; 11(7):436-9. PubMed ID: 15742339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of receptor-mediated actions of T-kinin.
    Gao X; Stewart JM; Vavrek RJ; Greenbaum LM
    Biochem Pharmacol; 1993 Nov; 46(9):1607-12. PubMed ID: 8240418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
    Cheronis JC; Whalley ET; Nguyen KT; Eubanks SR; Allen LG; Duggan MJ; Loy SD; Bonham KA; Blodgett JK
    J Med Chem; 1992 May; 35(9):1563-72. PubMed ID: 1578482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclic analogue of bradykinin possessing selective and prolonged biological activity.
    Chipens GI; Mutulis FK; Katayev BS; Klusha VE; Misina IP; Myshlyiakova NV
    Int J Pept Protein Res; 1981 Sep; 18(3):302-11. PubMed ID: 7341523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of bradykinin on calcium movements in rat uterus.
    Paegelow I; Kovács T; Pflieger G
    Acta Biol Med Ger; 1980; 39(4):509-12. PubMed ID: 7445897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and properties of new bradykinin potentiating peptides.
    Tominaga M; Stewart JM
    J Med Chem; 1975 Feb; 18(2):130-3. PubMed ID: 1120978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cyclic analogs of des-Arg9-[Leu8]bradykinin].
    Mutule IE; Mutulis FK; Rozite SKh; Porunkevich EA; Ratkevich MP
    Bioorg Khim; 1989 Mar; 15(3):325-34. PubMed ID: 2472797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The action of bradykinin and oxytocin on the isolated whole uterus and myometrium of the rat in oestrus.
    Whalley ET
    Br J Pharmacol; 1978 Sep; 64(1):21-8. PubMed ID: 568012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
    Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
    Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bradykinin receptor-like binding studied with iodinated analogues.
    Odya CE; Goodfriend TL; Peña C
    Biochem Pharmacol; 1980 Feb; 29(2):175-85. PubMed ID: 6153894
    [No Abstract]   [Full Text] [Related]  

  • 58. [Mechanism of action of cyclokinins].
    Myshliakova NV; Vitolinia RO; Golubeva VV; Afanas'eva GA; Klusha VE
    Biull Eksp Biol Med; 1983 Nov; 96(11):69-71. PubMed ID: 6315109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
    Hayashi MA; Murbach AF; Ianzer D; Portaro FC; Prezoto BC; Fernandes BL; Silveira PF; Silva CA; Pires RS; Britto LR; Dive V; Camargo AC
    J Neurochem; 2003 May; 85(4):969-77. PubMed ID: 12716428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bradykinin analogues containing N alpha-methyl amino acids.
    Mazur RH; James PA; Tyner DA; Hallinan EA; Sanner JH; Schulze R
    J Med Chem; 1980 Jul; 23(7):758-63. PubMed ID: 7401103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.